In a significant turn of events that has reverberated across the healthcare sector, Medtronic, a well-established manufacturer of medical devices, is currently entangled in a legal dispute. Medtronic now faces a class action lawsuit filed by users of its InPen® system in the Central District of California. The dispute centers around accusations of sharing a "treasure trove" of diabetes patient data with tech giant Google, a move that has generated considerable controversy. This alleged breach of patient confidentiality has raised concerns within the medical industry, with GlobalData suggesting that it may trigger increased scrutiny in the healthcare field. "MiniMed's disclosure of PII and PHI [personally identifiable information and protected health information] to Google is particularly problematic because Google provides web services — such as YouTube and Gmail — that give it access to InPen users' real identities and device identifiers," the attorneys wrote.